Frazier Life Sciences
在场
Frazier Life Sciences 的所有者是 Frazier Healthcare Partners.
Frazier Healthcare Partners 拥有 4家子公司，其中包括 Comprehensive Pharmacy Services、Elevate Patient Financial Solutions 和 Frazier Life Sciences。
他们在：
涉及Frazier Healthcare Partners的并购和融资。
高管
查看带有其 23 名主要高管的组织结构图
Frazier Life Sciences 搜索最多的简介
- Albert Cha, Co-Managing Partner
- Patrick Heron, Co-Managing Partner
- James Topper, Co-Managing Partner
高管在Frazier Life Sciences变化
- Lauren Mifflin已作为Vice President of Company Creation加入公司 (新闻发布的2023十二月1号).
高管在Frazier Healthcare Partners变化
- Peter Tornatore已作为Vice President of Investor Relations加入公司 (新闻发布的2023十月30号).
创建提醒
跟踪 Frazier Life Sciences 的高管变动
基金
Frazier Healthcare Partners 拥有 1,475 家竞争者，其中包括 Lloyds Development Capital (联合王国)、BlackRock (美国(美洲)) 和 WindRose Health Investors (美国(美洲))。
Popular M&A news in 基金
- Abrdn Private Equity Opportunities Trust将改名为Patria Capital Partners。 (公布2024四月30号).
- HMC Capital 已收购 StratCap (公布2024二月28号).
- Thomvest Ventures 刚刚宣布为 250 筹款数百万美元。 (公布2024一月17号).
基金 行业的其他推荐联系人
- Valor Equity Partners 企业 Antonio Gracias - Founder, Chief Executive Officer and Chief Investment Officer
- Vanguard 企业 Mortimer Buckley - Chairman of the Board and Chief Executive Officer (retiring in Dec 2024)
- Caisse de Dépôt et Placement du Québec 企业 Jean-Marc Arbaud - President and Chief Executive Officer of CDPQ Infra
消息
Frazier Life Sciences 的最新新闻稿
- Diagonal Therapeutics Launches with $128 Million in Financing to Pioneer a New Approach to Discovering and Developing Agonist Antibodies to Tackle the Underlying Causes of Severely Debilitating Diseases | Diagonal Therapeutics
- Mirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis
- Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline - Tubulis
- Applied Therapeutics Announces $100 Million Private Placement | Applied Therapeutics
- PepGen Announces Pricing of $80.1 Million Underwritten Offering of Common Stock | PepGen
- Frazier Life Sciences Strengthens Investment Team with Addition of Lin Mu, M.D., MBA as Senior Associate
- View more press releases Close
通过电子邮件
